Opnurasib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Opnurasib, covering 2026-04-02 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments [Phase 1, Phase 2]